Advertisement

Basic Phenomena Underlying Novel use of Cholinergic Agents, Anticholinesterases and Precursors in Neurological Including Peripheral and Psychiatric Disease

  • A. G. Karczmar
Part of the Advances in Behavioral Biology book series (ABBI, volume 25)

Abstract

This paper concerns the bases underlying clinical uses of peripherally and centrally acting cholinergic drugs, described elsewhere in this section. Certain additional uses of such drugs that, while not described in this volume, deserve advocacy will also be mentioned. Besides the clinical uses mention in the chapter there are some twenty classical indications for cholinergic and anticholinergic drugs and anticholinesterases (antiChE’s) that include glaucoma, gastric hypermotility, motion sickness and parkinsonian disease (49,64,65), as well as certain novel uses (as for example in anxiety or fear); these cannot be discussed here for lack of space.

Keywords

Motion Sickness Cholinergic System Contingent Negative Variation Cholinergic Agonist Cholinergic Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Akasu, T. and Karczmar, A.G. (1979): Fed. Proc. 38:430.Google Scholar
  2. 2.
    Akasu, T. and Karczmar, A.G. (1980): Neuropharmacology 19: 393–403.CrossRefGoogle Scholar
  3. 3.
    Aquilonius, S.M. and Eckernas, S.A. (1980): This volume.Google Scholar
  4. 4.
    Barbeau, A., Growdon, J.H. and Wurtman, R.J., eds (1979):Choline and Lecithin in Brain Disorders, Nutrition and the Brain, Vol.5, Raven Press, New York.Google Scholar
  5. 5.
    Barnes, L., Karczmar, A.G. and Ingerson, A. (1975): Pharmacologist 17:180.Google Scholar
  6. 6.
    Barnes, L., Karczmar, A.G. and Ingerson, A. (1976): Pharmacologist 18:202.Google Scholar
  7. 7.
    Battig, K. (1978): Behavioral Effects of Nicotine, Karger, Basel.Google Scholar
  8. 8.
    Blass, J.P., Gibson, G.E., Duffy, T.E. and Plum, F. (1980): This volume.Google Scholar
  9. 9.
    Bovet, D., Bovet-Nittl, F. and Oliverio, A. (1967): Ann. N.Y. Acad. Sci. 142:261–267.CrossRefGoogle Scholar
  10. 10.
    Bowers, M.B. Jr., Goodman, E. and Sim, V.N. (1964): J. Nerv. Ment. Dis. 138:389.Google Scholar
  11. 11.
    Carlton, P.L. (1968): IN Psychopharmacology – A Review of Progress 1957–67 (ed) D.H. Efron, US Govt. Printing Office PHS Publ. No.836, Washington D.C., pp. 125–135.Google Scholar
  12. 12.
    Davis, K.L., Berger, P.A., Hollister, L.E. and Barchas, J.D. (1978): Life Sci. 22:1865–1872.CrossRefGoogle Scholar
  13. 13.
    Davis, B.M. and Davis, K.L. (1979): IN Brain Acetylcholine and Neuropsychiatric Disease (eds) K.L. Davis and P.A. Berger, Plenum Press, New York, pp. 445–458.CrossRefGoogle Scholar
  14. 14.
    Deutsch, J.A. (1973): The Psychological Basis of Memory, Academic Press, New York.Google Scholar
  15. 15.
    DeRyck, M. and Teitelbaum, P. (1978): Physiol. Behav. 20:403–408.CrossRefGoogle Scholar
  16. 16.
    Domino, E.F. (1978): IN Neuropsychopharmacology: Proc. 10th Int. Congr. CINP (eds) P. Deniker, C. Radouco-Thomas and A. Villeneuve, Pergamon Press, Oxford, pp. 1655–1658.Google Scholar
  17. 17.
    Domino, E.F., Mathews, B., Taib, S.K., Demetriou, S.K. and Fucek, F. (1980): This volume.Google Scholar
  18. 18.
    Drachman, D.A. (1978): IN Psychopharmacology: A Generation of Progress (eds) M.A. Liptin, A. Di Mascio and K.F. Killam, Raven Press, New York, 651–652.Google Scholar
  19. 19.
    Drachman, D.B. (1978): New Eng. J. Med. 298:136–186.CrossRefGoogle Scholar
  20. 20.
    Dun, N.J. and Karczmar, A.G. (1970): This volume.Google Scholar
  21. 21.
    Eckernas, S.A. (1977): Acta Physiol. Scand. Suppl. 499:8–62.Google Scholar
  22. 22.
    Eckernas, S.A., Aquilonius, S.M., Hartvig, P., Lindstrom, B. and Osterman, P.O. (1980): This volume.Google Scholar
  23. 23.
    Flodmark, S. and Wrammer, T. (1945): Acta Physiol. Scand. 9:88–96.CrossRefGoogle Scholar
  24. 24.
    Frommel, E., Beck, M., Beck, I., Melkonian, T.D., Wyss, R., Vallette, F. and Ducommun, M. (1951): Actual. Pharmacol. 3:157–187.Google Scholar
  25. 25.
    Gillin, J.C., Mendelson, W.B., Sitaram, N. and Wyatt, R.J. (1978): Ann. Rev. Pharmacol. Toxicol. 18:563–579.CrossRefGoogle Scholar
  26. 26.
    Gillin, J.C., Sitaram, N. and Weingartner, H. (1980): This volume.Google Scholar
  27. 27.
    Goldner, R.D. (1967): Int. J. Neuropsychol. 3:234–238.Google Scholar
  28. 28.
    Haase, H.J. (1965): IN Actions of Neuroleptics. A Psychiatric, Neurologic and Pharmacological Investigation (eds) H.J. Haase and P.A.J. Jensen, North-Holland, Amsterdam.Google Scholar
  29. 29.
    Hanin, I., Spiker, D.G., Maliinger, A.G., Kopp, U., Himmelbach, J.M., Neil, J.F. and Kupfer, D.J. (1980): This volume.Google Scholar
  30. 30.
    Harris, CM., Davis, J.M. and Janowsky, D.S. (1979): IN Choline and Lecithin in Brain Disorders (eds) A. Barbeau, J.H. Growdon and R.J. Wurtman, Raven Press, New York, pp. 397–408.Google Scholar
  31. 31.
    Heilbronn, E. and Stalberg, E. (1978): J. Neurochem. 31:5–12.CrossRefGoogle Scholar
  32. 32.
    Hokfelt, T., Eide, R., Johansson, O., Ljungdahl, A., Schultzberg, M., Fuxe, K., Goldstein, M., Nilsson, G., Pernter, B., Terenius, L., Ganten, D., Jeffeoate, S.L., Rehfeld, J. and Said, S. (1978): IN Psychopharmacology: A Generation of Progress (eds) M.A. Lipton, A. Di Mascio and K.F. Killam, Raven Press, New York, pp. 39–66.Google Scholar
  33. 33.
    Hokin-Neaverson, M. (1977): Adv. Exp. Med. Biol. 83:429–446.CrossRefGoogle Scholar
  34. 34.
    Janowsky, D.S. and Davis, J.M. (1978): IN Psychiatric Disgnosis: Exploration of Biological Predictors (eds) H.S. Akiskal and W.L. Webb, Spectrum Publ., New York, pp. 263–278.Google Scholar
  35. 35.
    Jenden, D.J. (1977): Cholinergic Mechanisms and Psychopharmacology (ed) D.J. Jenden, Plenum Press, New York, pp. 139–162.Google Scholar
  36. 36.
    Jenden, D.J. (1979): IN Brain Acetylcholine and Neuropsychia-try Disease (eds) K.L. Davis and P.A. Berger, Plenum Press, New York, pp. 483–513.Google Scholar
  37. 37.
    Jenden, D.J. (1979): IN Choline and Lecithin in Brain Disorders: Nutrition and the Brain Vol. 5 (eds) A. Barbeau, J.H. Growdon and R.J. Wurtmen, Plenum Press, New York, pp. 13–24.Google Scholar
  38. 38.
    Jope, R.S., Jenden, D.J., Ehrlich, B.E. and Diamond, J.M. (1978): New Eng. J. Med. 299:833–834.Google Scholar
  39. 39.
    Jouvet, M. (1961): IN The Nature of Sleep (eds) G.E.W. Wolstenholme and M. O’Connor, J&A Churchill, London, pp. 188–208.Google Scholar
  40. 40.
    Jouvet, M. (1972): IN Brain and Human Behavior (eds) A.G. Karczmar and J.C. Eccles, Springer-Verlag, Berlin, pp. 131–161.CrossRefGoogle Scholar
  41. 41.
    Karczmar, A.G. (1963): IN Cholinesterases and Anticholinesterase Agents (ed) G.B. Koelle, Springer-Verlag, Berlin.Google Scholar
  42. 42.
    Karczmar, A.G. (1967): Ann. Rev. Pharmacol. 7:241–276.CrossRefGoogle Scholar
  43. 43.
    Karczmar, A.G. (1967): IN Physiological Pharmacology (eds) W.S. Root and F.G. Hofman, Academic Press, New York, pp. 164263.Google Scholar
  44. 44.
    Karczmar, A.G. (1970): Presentation at Regional Midwest EEG Meeting, April, 1971, Hines Vet. Adm. Hospital.Google Scholar
  45. 45.
    Karczmar, A.G. (1971): IN Advances in Neuropsychopharmacology (eds) O. Vinar, Z. Votava and P.B. Bradley, North-Holland, Amsterdam, pp. 655–680.Google Scholar
  46. 46.
    Karczmar, A.G. (1976): IN Biology of Cholinergic Function (eds) A.M. Goldberg and I. Hanin, Raven Press, New York, pp.345–449.Google Scholar
  47. 47.
    Karczmar, A.G. (1977): IN Cholinergic Mechanisms and Psychopharmacology (ed) D.J. Jenden, Plenum Press, New York, pp. 679–708.Google Scholar
  48. 48.
    Karczmar, A.G. (1978): IN Neuropsychopharmacology: Proc. 10th Congr. CINP (eds) P. Deniker, C. Radouco-Thomas and A. Ville-neuve, Pergamon Press, Oxford, pp. 581–608.Google Scholar
  49. 49.
    Karczmar, A.C. (1979): Dru Ther. 4:31–38.Google Scholar
  50. 50.
    Karczmar, A.G. (1979): IN Choline and Lecithin in Brain Disorders. Nutrition and the Brain, Vol. 5 (eds) A. Barbeau, J.H. Growdon and R.J. Wurtman, Raven Press, New York, pp. 161–175.Google Scholar
  51. 51.
    Karczmar, A.G, (1979): IN Brain Acetylcholine and Neuropsychiatric Disease (eds) K.L. Davis and P.A. Berger, Plenum Press, New York, pp. 265–310.CrossRefGoogle Scholar
  52. 52.
    Karczmar, A.G., Badrinath, K. and Koehn, G. (1979): HEW-IND No.16, 412, Loyola University Medical Center.Google Scholar
  53. 53.
    Karczmar, A.G. and Koehn, G. (1980): IN Neurochemistry and Clinical Neurology (eds) L. Battistin, G. Hashim and A. Lajtha, Alan R. Liss, Inc., New York (in press).Google Scholar
  54. 54.
    Karczmar, A.G., Longo, V.G. and Scotti de Carolis, A. (1970):Physiol. Behav. 5:17 5–182.Google Scholar
  55. 55.
    Karczmar, A.G. and Nishi, S. (1971): IN Advances in Cytopharmacology (eds) F. Demente and B. Ceccarelli, pp. 301–317.Google Scholar
  56. 56.
    Karczmar, A.G., Nishi, S., Minota, S. and Kindel, G. (1980): Gen. Pharmacol. 11:127–134.CrossRefGoogle Scholar
  57. 57.
    Karczmar, A.G. and Scudder, C.L. (1969): IN Aggressive Behavior (eds) S. Garattini and E.B. Sigg, Excerpta Medica, Amsterdam, pp. 223–229.Google Scholar
  58. 58.
    Karczmar, A.G., Scudder, C.L. and Richardson, D.L. (1973): Neurosci. Res. 159–244.Google Scholar
  59. 59.
    Kim, K.C. and Karczmar, A.G. (1967): Int. J. Neuropharmacol. 6:51–61.CrossRefGoogle Scholar
  60. 60.
    Klawans, H.A. Jr., Westheimer, R. and Goetz, CG. (1976): Dis. Nerv. Syst. 36.:267–275.Google Scholar
  61. 61.
    Koehn, G., Henderson, G. and Karczmar, A.G. (1980): Eur. J. Pharmacol. 61:167–174.CrossRefGoogle Scholar
  62. 62.
    Koehn, G. and Karczmar, A.G. (1978): Prog. Neuropsychopharmacol, 2:169–174.CrossRefGoogle Scholar
  63. 63.
    Koelle, G.B. (1963): IN Cholinesterases and Anticholinesterase Agents (ed) Springer-Verlag, Berlin, pp. 187–298.Google Scholar
  64. 64.
    Koelle, G.B. (1975): IN The Pharmacological Basis of Therapeutics (eds) L.S. Goodman and A. Gilman, MacMillan Publ. Co., New York, pp. 575–588.Google Scholar
  65. 65.
    Koelle, G.B. (1972): New Eng. J. Med. 286:1086–1088.CrossRefGoogle Scholar
  66. 66.
    Koketsu, K., Karczmar, A.G. and Kitamura, R. (1969): Int. J. Neuropharmacol. 8:329–336.CrossRefGoogle Scholar
  67. 67.
    Krnjevic, K., Puil, E. and Werman, P. (1976): Canad. J. Physiol. Pharmacol. 54:172–176.CrossRefGoogle Scholar
  68. 68.
    Krnjevic, K. and Reinhardt, W. (1979): Science 206:1321–1322.CrossRefGoogle Scholar
  69. 69.
    Kupfer, D.J. and Efwards, D.J. (1978): IN Interrelationship between Various Neurotransmitter Systems (eds) A.G. Karczmar and J. Glowinski, Pergamon Press, Oxford, pp. 609–622.Google Scholar
  70. 70.
    Lehmann, J. and Fibiger, H.C (1980): This volume.Google Scholar
  71. 71.
    Liberson, W.T. and Karczmar, A.G. (1969): IN Neuro Physiological and Behavioral Aspects of Psychotropic Drugs (eds) A.G. Karczmar and W.P. Koelle, CC.Thomas, Springfield, pp.161–178Google Scholar
  72. 72.
    Libet, B. (1976): IN SIF Cells: Structure and Function of the Small Intensely Fluorescent Sympathetic Cells (ed) Fogarty Int. Center, Proc. No.30, U.S. Govt. Printing Office, Washington, D.C., pp. 163–177.Google Scholar
  73. 73.
    Longo, V.G. (1962): Electroencephalograph Atlas for Pharmacological Research, Elsevier, Amsterdam.Google Scholar
  74. 74.
    Longo, V.G. (1966): Pharmacol. Rev. 18:965–996.Google Scholar
  75. 75.
    Longo, V.G. and Loizzo, A. (1973): IN Brain, Nerves and Synapses (eds) F.E. Bloom and G.H. Acheson, Kargar, Basel, pp. 46–54.Google Scholar
  76. 76.
    Lynch, H.D. and Anderson, M.H. (1976): Dis. Nerv. Syst. 36:648–652.Google Scholar
  77. 77.
    Magazanik, L.G. and Vyskocil, F. (1976): IN Motor Innervation of Muscle (ed) S. Thesleff, Academic Press, New York.Google Scholar
  78. 78.
    Maier, N.R.F. (1949): The Study of Behavior without Goal, McGaw, New York.Google Scholar
  79. 79.
    Marczynski, T.J. (1967): Ergeb. Physiol. 59:86–97.Google Scholar
  80. 80.
    Marczynski, T.J. (1978): IN Multidisciplinary Perspectives in Event Related Brain Potential Research (ed) D. Otto, U.S. Environmental Protection Agency, Washington, D.C.Google Scholar
  81. 81.
    Marczynski, T.J. (1978): IN Multidisciplinary Perspectives in Event Related Brain Potential Research (ed) D. Otto, U.S. Environmental Protection Agency, Washington, D.C.Google Scholar
  82. 82.
    McGeer, P.L., Eccles, J.C. and McGeer, E.G. (1978): Molecular Neurobiology of the Mammalian Brain, Plenum Press, New York.CrossRefGoogle Scholar
  83. 83.
    McGeer, P.L. and McGeer, E.G. (1979): IN Choline and Lecithin: Nutritrion and the Brain, Vol. 5 (eds) A. Barbeau, J.H. Growdon and R.J. Wurtman, Raven Press, New York, pp. 177–199Google Scholar
  84. 84.
    Millington, W.B., McCall, A.L. and Wurtman, R.J. (1979): IN Choline and Lecithin in Brain Disorders: Nutrition and the Brain Vol. 5 (eds) A. Barbeau, J.H. Growdon and R.J. Wurtman, Raven Press, New York, pp. 417–424.Google Scholar
  85. 85.
    Mollenauer, J., White, M., Plotnik, R. and Bradlee-Tiffany, P. (1979): Pharmacol. Biochem. Behav. 11:189.CrossRefGoogle Scholar
  86. 86.
    Nastuk, W.L. (1967): Fed. Proc. 26:1639.Google Scholar
  87. 87.
    Nastuk, W.L., Piascia, O.J. and Osserman, K.E. (1960): Proc. Soc. Exp. Biol. Med. 105:177–183.Google Scholar
  88. 88.
    Neubauer, H., Adams, M. and Redfern, P. (1975): Med. Hypoth. 1:32–34.CrossRefGoogle Scholar
  89. 89.
    Ohta, Y. and Karczmar, A.G. (1980): Fed. Proc. 39:409.Google Scholar
  90. 90.
    Olds, J. (1958): Science 127:315–324.CrossRefGoogle Scholar
  91. 91.
    Pedigo, N.W. and Dewey, W.L. (1980): This volume.Google Scholar
  92. 92.
    Pedigo, N.W., Dewey, W.L. and Harris, L.S. (1975): J. Pharmacol. Exp. Ther. 193:845–852.Google Scholar
  93. 93.
    Pfefferbaum, A., Davis, K.L., Coulter, C.L., Mohs, R.C. and Kopell, B.S. (1979): IN Brain Acetylcholine and Neuropsychia trie Disease (eds) K.L. Davis and P.A. Berger, Plenum Press, New York, pp. 345–360.CrossRefGoogle Scholar
  94. 94.
    Plotnik, R., Mollenauer, S.O. and Snyder, E.F. (1974): J. Comp Physiol. Psychol. 86: 1074–1078.CrossRefGoogle Scholar
  95. 95.
    Pujol, J.F., Keane, P.E. and Jouvet, M. (1978): IN Interrelationships between Various Neurotransmitter Systems (eds) A.G. Karczmar and J. Glowinski, Pergamon Press, Oxford, pp. 559–568.Google Scholar
  96. 96.
    Samanin, R. and Valzelli, L. (1971): Eur. J. Pharmacol. 16:298–302.CrossRefGoogle Scholar
  97. 97.
    Schildkraut, J.J. (1970): Neuropsychopharmacology and the Affective Disorders, Little, Brown & Co., Boston.Google Scholar
  98. 98.
    Silbergeld, E.K. and Goldberg, A.M. (1976): IN Biology of Cholinergic Function (eds) A.M. Goldberg and I. Hanin, Raven Press, New York, pp. 619–645.Google Scholar
  99. 99.
    Singh, M.M. and Kay, S.R. (1978): Neuropsychobiology 4. 288–304.CrossRefGoogle Scholar
  100. 100.
    Singh, M.M. and Lai, J. (1979): Proc. end World. Congr. Biol. Psych., Elsevier, Amersterdam.Google Scholar
  101. 101.
    Sitaram, N., Buchsbaum, M.S. and Christian, G.J. (1977): Eur. J. Pharmacol. 42:285–290.CrossRefGoogle Scholar
  102. 102.
    Sitaram, N. and Gillin, J.C. (1980): This volume.Google Scholar
  103. 103.
    Sitaram, N., Wyatt, R.J., Dawson, S. and Gillin, J.C. (1976): Science 191:1281–1282.CrossRefGoogle Scholar
  104. 104.
    Slaughter, D. and Gross, E.G. (1940): J. Pharmacol. Exp. Ther. 68:96–103.Google Scholar
  105. 105.
    Stein, L. (1968): IN Psychopharmacology: A Review of Progress (ed) D. Efron, Govt. Printing Office, Publ. No. 836, Washington, D.C. 105–123.Google Scholar
  106. 106.
    Szerb, J.C. (1977): IN Cholinergic Mechanisms and Psychopharmacology (ed) D.J. Jenden, Plenum Press, New York, pp. 49–60.Google Scholar
  107. 107.
    Teitelbaum, H., Lee, J.F. and Johannessen, J.N. (1975): Science, 188:1114.Google Scholar
  108. 108.
    Thesleff, S. (1959): J. Physiol. 148:659–664.Google Scholar
  109. 109.
    Thesleff, S. and Quastel, D.M.J. (1965): Ann. Rev. Pharmacol. 5:263–284.CrossRefGoogle Scholar
  110. 110.
    Yang, H.Y., Hong, J.S. and Costa, E. (1977): Neuropharmacology 16:303–308.CrossRefGoogle Scholar
  111. 111.
    Van Andel, H. (1959): IN Neuropsychopharmacology (eds) P.B. Bradley, P. Deniker and C. Radouco-Thomas, Elsevier, Amsterdam, pp. 701–703.Google Scholar
  112. 112.
    Wecker, L. and Schmidt, D.E. (1980): Brain Res. 184:234–240.CrossRefGoogle Scholar
  113. 113.
    Weinberg, C.B. and Hall, Z.W. (1979): Proc. Nat. Acad. Sci. 76:504.Google Scholar
  114. 114.
    Wikler, A. (1952): Proc. Soc. Exp. Biol. Med. 79:261–265.Google Scholar
  115. 115.
    Wurtman, R.J. (1979): IN Choline and Lecithin in Brain Dis-orders: Nutrition and the Brain, Vol. 5 (eds) J.H. Growdon and R.J. Wurtman, Raven Press, New York, pp. 7–12.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • A. G. Karczmar
    • 1
  1. 1.Department of Pharmacology and Institute for NeuropharmacologyLoyola University Medical CenterMaywoodUSA

Personalised recommendations